Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting course, which affects 2–3% of the worldwide population. The progressive acquisitions of the inflammatory pathways involved in the development of psoriasis have led to the identification of the key molecules of t...
Saved in:
Main Authors: | Anna Campanati, Andrea Marani, Emanuela Martina, Federico Diotallevi, Giulia Radi, Annamaria Offidani |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/16c73e2b3e974af0b68bc99a31453b9d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Erythrodermic psoriasis: pathophysiology and current treatment perspectives
by: Singh RK, et al.
Published: (2016) -
Psoriasis and systemic lupus erythematosus in children – literature review based on case report
by: Izabela Dybowska-Gołota, et al.
Published: (2020) -
Common Fundamentals of Psoriasis and Depression
by: Stefanie Hölsken, et al.
Published: (2021) -
Local effects of adipose tissue in psoriasis and psoriatic arthritis
by: Kruglikov IL, et al.
Published: (2017) -
Management of scalp psoriasis: current perspectives
by: Blakely K, et al.
Published: (2016)